Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Short-Term Debt repayments (2016 - 2023)

Lifecore Biomedical, Inc. \De\ has reported Short-Term Debt repayments over the past 12 years, most recently at $12.2 million for Q2 2023.

  • Quarterly results put Short-Term Debt repayments at $12.2 million for Q2 2023, up 22.4% from a year ago — trailing twelve months through May 2023 was $54.6 million (up 23.87% YoY), and the annual figure for FY2024 was $146.7 million, up 168.49%.
  • Short-Term Debt repayments for Q2 2023 was $12.2 million at Lifecore Biomedical, Inc. \De\, down from $41.6 million in the prior quarter.
  • Over the last five years, Short-Term Debt repayments for LFCR hit a ceiling of $119.4 million in Q1 2021 and a floor of -$19.4 million in Q4 2020.
  • Median Short-Term Debt repayments over the past 5 years was $17.0 million (2019), compared with a mean of $22.1 million.
  • Biggest five-year swings in Short-Term Debt repayments: skyrocketed 1033.33% in 2019 and later crashed 152.43% in 2020.
  • Lifecore Biomedical, Inc. \De\'s Short-Term Debt repayments stood at $37.0 million in 2019, then crashed by 152.43% to -$19.4 million in 2020, then surged by 141.24% to $8.0 million in 2021, then plummeted by 90.0% to $800000.0 in 2022, then soared by 1430.0% to $12.2 million in 2023.
  • The last three reported values for Short-Term Debt repayments were $12.2 million (Q2 2023), $41.6 million (Q1 2023), and $800000.0 (Q4 2022) per Business Quant data.